These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 33620646)
1. Human Campylobacteriosis-A Serious Infectious Threat in a One Health Perspective. Heimesaat MM; Backert S; Alter T; Bereswill S Curr Top Microbiol Immunol; 2021; 431():1-23. PubMed ID: 33620646 [TBL] [Abstract][Full Text] [Related]
2. Molecular Targets in Heimesaat MM; Backert S; Alter T; Bereswill S Biomolecules; 2023 Feb; 13(3):. PubMed ID: 36979344 [TBL] [Abstract][Full Text] [Related]
3. Murine Models for the Investigation of Colonization Resistance and Innate Immune Responses in Campylobacter Jejuni Infections. Mousavi S; Bereswill S; Heimesaat MM Curr Top Microbiol Immunol; 2021; 431():233-263. PubMed ID: 33620654 [TBL] [Abstract][Full Text] [Related]
4. Knowledge gaps in control of Campylobacter for prevention of campylobacteriosis. Hansson I; Sandberg M; Habib I; Lowman R; Engvall EO Transbound Emerg Dis; 2018 May; 65 Suppl 1():30-48. PubMed ID: 29663680 [TBL] [Abstract][Full Text] [Related]
5. [Microbiological diagnosis of infections caused by Campylobacter jejuni and Campylobacter coli in humans]. Rokosz N; Rastawicki W; Wołkowicz T Postepy Hig Med Dosw (Online); 2014 Jan; 68():48-56. PubMed ID: 24491895 [TBL] [Abstract][Full Text] [Related]
6. Oral curcumin ameliorates acute murine campylobacteriosis. Heimesaat MM; Mousavi S; Lobo de Sá FD; Peh E; Schulzke JD; Bücker R; Kittler S; Bereswill S Front Immunol; 2024; 15():1363457. PubMed ID: 38855111 [TBL] [Abstract][Full Text] [Related]
7. One health approach of campylobacteriosis in Egypt: An emerging zoonotic disease. Abd El-Ghany WA J Infect Dev Ctries; 2019 Nov; 13(11):956-960. PubMed ID: 32087066 [TBL] [Abstract][Full Text] [Related]
8. The Data Behind Risk Analysis of Campylobacter Jejuni and Campylobacter Coli Infections. Ben Romdhane R; Merle R Curr Top Microbiol Immunol; 2021; 431():25-58. PubMed ID: 33620647 [TBL] [Abstract][Full Text] [Related]
9. Control strategies against Campylobacter at the poultry production level: biosecurity measures, feed additives and vaccination. Meunier M; Guyard-Nicodème M; Dory D; Chemaly M J Appl Microbiol; 2016 May; 120(5):1139-73. PubMed ID: 26541243 [TBL] [Abstract][Full Text] [Related]
11. Shifts in the Molecular Epidemiology of Campylobacter jejuni Infections in a Sentinel Region of New Zealand following Implementation of Food Safety Interventions by the Poultry Industry. Nohra A; Grinberg A; Marshall JC; Midwinter AC; Collins-Emerson JM; French NP Appl Environ Microbiol; 2020 Feb; 86(5):. PubMed ID: 31862724 [TBL] [Abstract][Full Text] [Related]
12. Global epidemiology of campylobacteriosis and the impact of COVID-19. Liu F; Lee SA; Xue J; Riordan SM; Zhang L Front Cell Infect Microbiol; 2022; 12():979055. PubMed ID: 36519137 [TBL] [Abstract][Full Text] [Related]
14. Poultry as a host for the zoonotic pathogen Campylobacter jejuni. Hermans D; Pasmans F; Messens W; Martel A; Van Immerseel F; Rasschaert G; Heyndrickx M; Van Deun K; Haesebrouck F Vector Borne Zoonotic Dis; 2012 Feb; 12(2):89-98. PubMed ID: 22133236 [TBL] [Abstract][Full Text] [Related]
15. Update on human Campylobacter jejuni infections. Kirkpatrick BD; Tribble DR Curr Opin Gastroenterol; 2011 Jan; 27(1):1-7. PubMed ID: 21124212 [TBL] [Abstract][Full Text] [Related]
16. Microbial food borne pathogens. Campylobacter jejuni. Altekruse SF; Swerdlow DL; Stern NJ Vet Clin North Am Food Anim Pract; 1998 Mar; 14(1):31-40. PubMed ID: 9532665 [TBL] [Abstract][Full Text] [Related]
17. Relevance of Campylobacter to public health--the need for a One Health approach. Gölz G; Rosner B; Hofreuter D; Josenhans C; Kreienbrock L; Löwenstein A; Schielke A; Stark K; Suerbaum S; Wieler LH; Alter T Int J Med Microbiol; 2014 Oct; 304(7):817-23. PubMed ID: 25266744 [TBL] [Abstract][Full Text] [Related]